Edition:
United States

Solid Biosciences Inc (SLDB.OQ)

SLDB.OQ on NASDAQ Stock Exchange Global Select Market

34.55USD
19 Oct 2018
Change (% chg)

$-0.95 (-2.68%)
Prev Close
$35.50
Open
$35.23
Day's High
$35.85
Day's Low
$33.67
Volume
70,196
Avg. Vol
80,657
52-wk High
$54.51
52-wk Low
$6.83

Latest Key Developments (Source: Significant Developments)

Solid Biosciences Qtrly Loss Per Share $0.52
Friday, 10 Aug 2018 07:30am EDT 

Aug 10 (Reuters) - Solid Biosciences Inc ::SOLID BIOSCIENCES REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.SOLID BIOSCIENCES INC QTRLY LOSS PER SHARE $0.52.SOLID BIOSCIENCES - ENDED Q2 WITH $162.8 MILLION IN CASH, CASH EQUIVALENTS AND AVAILABLE-FOR-SALE SECURITIES AS COMPARED TO $69.1 MILLION AS OF DEC 31, 2017.  Full Article

Solid Biosciences Announces FDA Removes Clinical Hold On SGT-001
Monday, 18 Jun 2018 07:00am EDT 

June 18 (Reuters) - Solid Biosciences Inc ::SOLID BIOSCIENCES ANNOUNCES FDA REMOVES CLINICAL HOLD ON SGT-001.SOLID BIOSCIENCES INC - ACTIVITIES TO RESUME ENROLLMENT IN IGNITE DMD PHASE I/II CLINICAL TRIAL ARE UNDERWAY.SOLID BIOSCIENCES INC - SOLID NOW EXPECTS TO REPORT INITIAL DATA FROM A PRE-SPECIFIED INTERIM ANALYSIS OF IGNITE DMD IN SECOND HALF OF 2019.SOLID BIOSCIENCES - FDA LIFTED CLINICAL HOLD ON CO'S PHASE I/II CLINICAL TRIAL FOR SGT-001 FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.  Full Article

Boxer Capital Reports 6.2 Pct Passive Stake In Solid Biosciences
Friday, 18 May 2018 06:23pm EDT 

May 18 (Reuters) - Solid Biosciences Inc ::BOXER CAPITAL, LLC REPORTS 6.2 PERCENT PASSIVE STAKE IN SOLID BIOSCIENCES INC AS OF MAY 9 - SEC FILING.  Full Article

Solid Biosciences Reports Quarterly Loss Per Share Of $0.54
Thursday, 10 May 2018 07:30am EDT 

May 10 (Reuters) - Solid Biosciences Inc ::SOLID BIOSCIENCES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.SOLID BIOSCIENCES INC QUARTERLY LOSS PER SHARE $0.54.  Full Article

Solid Biosciences Provides Update On SGT-001 Clinical Development Program For Duchenne Muscular Dystrophy
Wednesday, 18 Apr 2018 07:30am EDT 

April 18 (Reuters) - Solid Biosciences Inc ::SOLID BIOSCIENCES PROVIDES UPDATE ON SGT-001 CLINICAL DEVELOPMENT PROGRAM FOR DUCHENNE MUSCULAR DYSTROPHY.SOLID BIOSCIENCES INC - FULL CLINICAL HOLD LETTER FROM FDA RECEIVED; COMPANY TO RESPOND IN COMING WEEKS.SOLID BIOSCIENCES INC - MANUFACTURING-RELATED PARTIAL CLINICAL HOLD ON HIGH DOSE OF SGT-001 RESOLVED.SOLID BIOSCIENCES - GOT LETTER FROM U.S. FDA RELATING TO PREVIOUSLY-ANNOUNCED FULL CLINICAL HOLD ON IGNITE DMD TRIAL.SOLID BIOSCIENCES - FULL CLINICAL HOLD WAS IN RESPONSE TO CO'S REPORT OF A SERIOUS ADVERSE EVENT IN FIRST PATIENT DOSED WITH SGT-001 IN IGNITE DMD.SOLID BIOSCIENCES - FDA SAYS CO ADDRESSED MANUFACTURING-RELATED QUESTIONS LEADING TO PARTIAL CLINICAL HOLD ON HIGH DOSE OF SGT-001 IN IGNITE DMD.  Full Article

RA Capital Management Reports A 7.9 Pct Stake In Solid Biosciences
Friday, 9 Feb 2018 04:40pm EST 

Feb 9 (Reuters) - Solid Biosciences Inc ::RA CAPITAL MANAGEMENT, LLC REPORTS A 7.9 PERCENT STAKE IN SOLID BIOSCIENCES INC AS OF JANUARY 30, 2018 - SEC FILING.RA CAPITAL MANAGEMENT LLC SAYS SOLID BIOSCIENCES INC'S COMMON STOCK REPORTED HEREIN FOR INVESTMENT PURPOSES.  Full Article

Solid Biosciences Shares Debut About 60 Pct Above IPO Price
Friday, 26 Jan 2018 11:35am EST 

Jan 26 (Reuters) - :SOLID BIOSCIENCES SHARES OPEN AT $25.50 IN DEBUT ON THE NASDAQ VERSUS IPO PRICE OF $16.00 PER SHARE.  Full Article

Solid Biosciences Announces Pricing Of Initial Public Offering
Thursday, 25 Jan 2018 07:44pm EST 

Jan 25 (Reuters) - Solid Biosciences Llc ::SOLID BIOSCIENCES ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.SOLID BIOSCIENCES LLC SAYS ANNOUNCED PRICING OF ITS IPOOF 7.8 MILLION SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF $16.00 PER SHARE.  Full Article

BRIEF-Boxer Capital Reports 6.2 Pct Passive Stake In Solid Biosciences

* BOXER CAPITAL, LLC REPORTS 6.2 PERCENT PASSIVE STAKE IN SOLID BIOSCIENCES INC AS OF MAY 9 - SEC FILING Source text: (https://bit.ly/2GwS8zg) Further company coverage: